Associate Health Scientist to lead a research line in Molecular Imaging and Nanomedicine applied to the cardiovascular system*

*TEMPORARY CONTRACT “Contrato de investigador/a distinguido/a” Art. 23 Ley 14/2011 de la Ciencia, la Tecnología y la Innovación)

The Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) (CNIC) has been conceived to develop research of excellence, competitive and of international relevance in relation to cardiovascular diseases. The CNIC has a research center of 24,000 m², located in Madrid, with more than 6,000 m² for laboratories equipped with a state-of-the-art infrastructure and equipment.

 Functions:

The selected candidate will be responsible for the development of the research lines of a laboratory, which is expected to focus on the development of molecular imaging technologies and nanomedicine to improve diagnosis and treatment of cardiovascular disease. Moreover, she/he will be expected to obtain extramural funding from the most competitive national and international sources to finance such projects, and to publish scientific results in international journals of the highest impact factor in the cardiovascular field, and/or general medicine field, and/or multidisciplinary sciences field. The selected candidate will supervise the work of all members of the group, including research and technical staff. Other tasks include the coordination and management work requested by CNIC leadership including participation in committees and helping in other needs that may arise.

Mandatory Requirements:

1. PhD in the field of Life Sciences (Biology, Chemistry, Medicine, etc.)
2. A minimum of 5 years and no more than 10 years of experience leading a research group in the field of molecular imaging or nanomedicine in an internationally recognized research center.
3. A minimum of 3 articles as main author (first, last or corresponding author) in journals in the field of molecular imaging and/or cardiovascular disease in the last 5 years (i.e., since July 2019).
4. Experience as Principal Investigator and/or Coordinator in competitive research grants obtained from national and/or international competitive funding sources in the last 5 years (i.e., official start date of projects July 2019 onwards).
5. Main topic of research in the field of nanomedicine and molecular imaging applied to the cardiovascular system.

Valuable Requirements:

• C1. Scientific production: publications as main author (first, last or corresponding author) in journals in the field of nanomedicine and molecular imaging applied to cardiovascular disease in the previous 5 years (i.e., date of publication since July 2019). Only published papers (or available online ahead of print in the journal) will be evaluated. The CV must include the complete list of authors, the journal´s impact factor and ranking in the year of publication for each publication published since 2019.

This criterion will be valued as a whole according to the scientific impact of the papers (journal ranking and citation record) and according to the number of papers published as main author (first, last or corresponding author).

• C2. Fundraising (international): Competitive projects obtained from international funding sources as Principal Investigator and/or Coordinator in the previous 5 years (i.e., official start date of projects July 2019 onwards). The CV must include each project, indicating the role of the candidate in the grant, amount granted, period of funding, and funding agency.

This criterion will be valued as a whole according to the relevance of the funding source (being European Commission-funded projects considered the highest), the amount granted, and the number of projects.

• C3. Fundraising (national): Projects obtained from national funding sources as principal investigator or coordinator in the previous 5 years (i.e. official start date of projects July 2019 onwards).

This criterion will be valued according to the relevance of the funding source, the amount granted, and the number of projects. The CV must include each project, indicating the role of the candidate in the grant, amount granted, period of funding, and funding agency.

• C4. International recognition: Participation in international committees/ boards, grant evaluation panels, editorial boards, and invited seminars/conferences in international centers/meetings in the previous 5 years (i.e., since 2019).

This criterion will be valued as a whole according to the relevance of the boards, role played in these, and number of activities.

• C5. Cardiovascular focus: Nature of the papers published as main author (first, last or corresponding author) and of the projects as principal investigator in the previous 5 years (i.e. since 2019) in the field of nanomedicine and molecular imaging applied to the cardiovascular system.

This criterion will be evaluated as the weight of nanomedicine and molecular imaging applied to the cardiovascular system in the overall scientific production and fundraising of the candidate.

• C6. Underrepresentation of gender by category, in accordance with Action S1 of the 2021-2024 Equality Plan, POSITIVE ACTION IN CALLS FOR POSTS.

We offer

• A research position in a consolidated Research Center of international scientific relevance.
• Access to state-of-the art infrastructures and advanced technologies.
• Integration into an excellent scientific environment.
• Immediate incorporation adaptable to the candidate circumstances
• 5-years temporary position as “Contrato de investigador/a distinguido/a”. Distinguished investigator contract regulated by the article 23 of the Spanish Law, on Science, Technology and Innovation (texto refundido Ley 14/2011, de 1 de junio, de la Ciencia, la Tecnología y la Innovación).

Selection Plan

The candidate with the highest score will be hired given the total score is higher than 80 points (C1-C6).

Evaluation Process:

Mandatory criteria will be evaluated by HHRR assisted by the scientific leadership of CNIC if needed. Candidates not fulfilling any of the mandatory criteria will be notified and allowed to make allegations (enclosing supporting material). Only candidacies fulfilling all mandatory criteria will pass to the evaluation by the commission here described. The evaluation commission will only evaluate valuable criteria.

 The evaluation commission will be composed by 3 members of CNIC’s Scientific Advisory Board, and two members of CNIC’s Scientific Direction.

 In the event of absence of any of the evaluators an alternate evaluator will be appointed.

The CNIC guarantees, in its field of action, the principle of equality in access to employment, and cannot establish any discrimination, direct or indirect, based on reasons of origin, including racial or ethnic, sex, age, marital status, religion or convictions, political opinion, sexual orientation and identity, gender expression, sexual characteristics, union affiliation, social condition, language within the State and disability, provided that the workers are in conditions of aptitude to carry out the work or employment for which try they are assigned.

By participating in the selection process, the participant agrees that their data appear in the public resolutions of the selection process. Such resolutions (provisional list of admitted and excluded, definitive list of admitted and excluded and resolution of the process) are published on the CNIC website.